{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:31:34Z","timestamp":1787959894696,"version":"build-2784847793"},"update-to":[{"DOI":"10.1002\/14651858.cd003336.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000}}],"reference-count":52,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003336.pub4","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T06:50:39Z","timestamp":1621320639000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Anticoagulation versus placebo for heart failure in sinus rhythm"],"prefix":"10.1002","volume":"2021","author":[{"given":"Eduard","family":"Shantsila","sequence":"additional","affiliation":[{"name":"University of Birmingham, Institute of Cardiovascular Sciences; City Hospital, Sandwell and West Birmingham Hospitals NHS Trust; Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Kozie\u0142","sequence":"additional","affiliation":[{"name":"Liverpool Centre for Cardiovascular Science; University of Liverpool and Liverpool Heart & Chest Hospital; Liverpool UK"},{"name":"1st Department of Cardiology and Angiology; Silesian Centre for Heart Diseases; Zabrze Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory YH","family":"Lip","sequence":"additional","affiliation":[{"name":"Institute of Ageing and Chronic Disease; University of Liverpool; Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,5,18]]},"reference":[{"issue":"42","key":"10.1002\/14651858.CD003336.pub4-BIB0001|cit1","first-page":"3593-602","article-title":"A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial","volume":"40","author":"Mehra","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD003336.pub4-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1056\/NEJMoa1808848","article-title":"Rivaroxaban in patients with heart failure, sinus rhythm, and coronary disease","volume":"379","author":"Zannad","year":"2018","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003336.pub4-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ejheart.2006.02.012","article-title":"Efficacy of antithrombotic therapy in chronic heart failure: the HELAS study","volume":"8","author":"Cokkinos","year":"2006","journal-title":"European Journal of Heart Failure"},{"key":"10.1002\/14651858.CD003336.pub4-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ahj.2004.03.010","article-title":"The Warfarin\/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure","volume":"148","author":"Cleland","year":"2004","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD003336.pub4-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0002-8703(50)90129-3","article-title":"The effects of dicumarol upon the mortality and incidence of thromboembolic complications in congestive heart failure","volume":"39","author":"Anderson","year":"1950","journal-title":"American Heart Journal"},{"issue":"23","key":"10.1002\/14651858.CD003336.pub4-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","article-title":"Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)","volume":"316","author":"CONSENSUS Trial Study Group","year":"1987","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD003336.pub4-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S1388-9842(02)00028-4","article-title":"Antithrombotic therapy is associated with better survival in patients with severe heart failure and left ventricular systolic dysfunction (EPICAL study)","volume":"4","author":"Echemann","year":"2002","journal-title":"European Journal of Heart Failure"},{"key":"10.1002\/14651858.CD003336.pub4-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0002-9149(81)90534-8","article-title":"The natural history of idiopathic dilated cardiomyopathy","volume":"47","author":"Fuster","year":"1981","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD003336.pub4-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"867","DOI":"10.7326\/0003-4819-37-5-867","article-title":"A study of the beneficial effects of anticoagulant therapy in congestive heart failure","volume":"37","author":"Griffith","year":"1952","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD003336.pub4-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1056\/NEJM195002092420603","article-title":"Dicumarol prophylaxis of thromboembolic disease in congestive heart failure","volume":"242","author":"Harvey","year":"1950","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003336.pub4-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1055\/s-0038-1657888","article-title":"Prevention of arterial and pulmonary embolism by oral anticoagulants in patients with dilated cardiomyopathy","volume":"54","author":"Kyrle","year":"1985","journal-title":"Thrombosis and Haemostasis"},{"issue":"Suppl I","key":"10.1002\/14651858.CD003336.pub4-BIB0012|cit12","first-page":"603","article-title":"Low risk of arterial embolization in outpatients awaiting cardiac transplantation","volume":"88","author":"Natterson","year":"1993","journal-title":"Circulation"},{"issue":"Suppl A","key":"10.1002\/14651858.CD003336.pub4-BIB0013|cit13","first-page":"218A","article-title":"The effect of warfarin on prevalence of stroke in severe heart failure","volume":"21","author":"Falk","year":"1993","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD003336.pub4-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJM199701233360403","article-title":"Ventricular dysfunction and the risk of stroke after myocardial infarction","volume":"336","author":"Loh","year":"1997","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD003336.pub4-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0735-1097(98)00006-0","article-title":"Warfarin anticoagulation and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction","volume":"31","author":"Al-Khadra","year":"1998","journal-title":"Journal of the American College of Cardiology"},{"issue":"Suppl VI","key":"10.1002\/14651858.CD003336.pub4-BIB0016|cit16","first-page":"94","article-title":"Incidence of thromboembolic events in congestive heart failure","volume":"87","author":"Dunkman","year":"1993","journal-title":"Circulation"},{"issue":"1","key":"10.1002\/14651858.CD003336.pub4-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-2141.2004.05162.x","article-title":"The risk of overanticoagulation in patients with heart failure on coumarin anticoagulants","volume":"127","author":"Visser","year":"2004","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD003336.pub4-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1056\/NEJMoa1202299","article-title":"Warfarin and aspirin in patients with heart failure and sinus rhythm","volume":"366","author":"Homma","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"10.1002\/14651858.CD003336.pub4-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1161\/CIRCULATIONAHA.108.801753","article-title":"Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial","volume":"119","author":"Messie","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD003336.pub4-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJM194811042391902","article-title":"Dicumarol therapy in congestive heart failure","volume":"239","author":"Wishart","year":"1948","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD003336.pub4-BIB0021|cit21","first-page":"226","article-title":"Real-world characteristics of hospitalized frail elderly patients with atrial fibrillation: can we improve the current prescription of anticoagulants?","volume":"13","author":"Annoni","year":"2016","journal-title":"Journal of Geriatric Cardiology: JGC"},{"key":"10.1002\/14651858.CD003336.pub4-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1056\/NEJM199011293232201","article-title":"The effect of low-dose warfarin on the risk of stroke in patients with non-rheumatic atrial fibrillation","volume":"323","author":"The Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF) Investigators","year":"1990","journal-title":"New England Journal of Medicine"},{"issue":"17","key":"10.1002\/14651858.CD003336.pub4-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1136\/heartjnl-2018-314381","article-title":"Anticoagulation therapy in heart failure and sinus rhythm: a systematic review and meta-analysis","volume":"105","author":"Beggs","journal-title":"Heart"},{"key":"10.1002\/14651858.CD003336.pub4-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1053\/euhj.1997.0859","article-title":"Influence of concomitant disease on patterns of hospitalisation in patients with heart failure discharged from Scottish hospitals in 1995","volume":"19","author":"Brown","year":"1998","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD003336.pub4-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/archinte.1977.03630140045012","article-title":"Management of anticoagulation in outpatients: experience with an anticoagulation service in a municipal hospital setting","volume":"137","author":"Davis","year":"1977","journal-title":"Archives of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD003336.pub4-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.archger.2012.12.006","article-title":"Risk factors for falls in older people in nursing homes and hospitals. A systematic review and meta-analysis","volume":"56","author":"Deandrea","year":"2013","journal-title":"Archives of Gerontology and Geriatrics"},{"key":"10.1002\/14651858.CD003336.pub4-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0735-1097(97)00176-9","article-title":"Differences between primary care physicians and cardiologists in the management of congestive heart failure: relationship to practice guidelines","volume":"30","author":"Edep","year":"1997","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD003336.pub4-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"2455-64","DOI":"10.1093\/eurheartj\/ehw213","article-title":"Antithrombotic therapy in heart failure patients with and without atrial fibrillation: update and future challenges\u00a0","volume":"37","author":"Ferreira","year":"2016","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD003336.pub4-BIB0029|cit29","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003336.pub4-BIB0030|cit30","first-page":"17","article-title":"Venous thromboembolism in medical patients - the scope of the problem","volume":"29","author":"Haas","journal-title":"Seminars in Thrombosis and Hemostasis"},{"key":"10.1002\/14651858.CD003336.pub4-BIB0031|cit31","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"issue":"5","key":"10.1002\/14651858.CD003336.pub4-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612.","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"42","author":"Hindricks","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD003336.pub4-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.0954-6820.1976.tb08250.x","article-title":"Problems encountered in long-term treatment with anticoagulants","volume":"200","author":"Husted","year":"1976","journal-title":"Acta Medica Scandinavica"},{"issue":"12","key":"10.1002\/14651858.CD003336.pub4-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"e004873","DOI":"10.1161\/CIRCHEARTFAILURE.117.004873","article-title":"National burden of heart failure events in the United States, 2006 to 2014","volume":"11","author":"Jackson","journal-title":"Circulation. Heart Failure"},{"key":"10.1002\/14651858.CD003336.pub4-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0002-9343(89)80689-8","article-title":"Major bleeding in outpatients treated with warfarin. Incidence and prediction by factors known at the start of outpatient therapy","volume":"87","author":"Landefeld","year":"1989","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD003336.pub4-BIB0036|cit36","doi-asserted-by":"crossref","unstructured":"Lefebvre C Glanville J Briscoe S Littlewood A Marshall C Chapter 4: Searching for and selecting studies. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.0 (updated July 2019). Cochrane, 2019 Available from www.training.cochrane.org\/handbook","DOI":"10.1002\/9781119536604.ch4"},{"issue":"7","key":"10.1002\/14651858.CD003336.pub4-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Medicine"},{"issue":"14","key":"10.1002\/14651858.CD003336.pub4-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC","volume":"33","author":"McMurray","journal-title":"European Heart Journal"},{"issue":"5","key":"10.1002\/14651858.CD003336.pub4-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1161\/CIRCULATIONAHA.113.003126","article-title":"Predicting the risk of venous thromboembolism in patients hospitalized with heart failure","volume":"130","author":"Mebazaa","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD003336.pub4-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1001\/jama.2015.10725","article-title":"Assessment of the CHA\u2082DS\u2082-VASc score in predicting ischemic stroke, thromboembolism, and death in patients with heart failure with and without atrial fibrillation","volume":"314","author":"Melgaard","year":"2015","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD003336.pub4-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0140-6736(89)91200-2","article-title":"Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK Study","volume":"I","author":"Petersen","year":"1989","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003336.pub4-BIB0042|cit42","first-page":"2129-200","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","journal-title":"European Heart Journal"},{"issue":"5","key":"10.1002\/14651858.CD003336.pub4-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1002\/ejhf.1789","article-title":"Prevalence of risk of thrombosis and of bleeding and antithrombotic treatment in patients with heart failure","volume":"22","author":"Pozzoli","journal-title":"European Journal of Heart Failure"},{"key":"10.1002\/14651858.CD003336.pub4-BIB0044|cit44","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2020"},{"issue":"4","key":"10.1002\/14651858.CD003336.pub4-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","journal-title":"Journal of Thrombosis and Haemostasis: JTH"},{"key":"10.1002\/14651858.CD003336.pub4-BIB0046|cit46","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing summary of findings tables and grading the certainty of the evidence. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions V ersion 6.1 (updated September 2020). Cochrane, 2020 Available from www.training.cochrane.org\/handbook"},{"issue":"1","key":"10.1002\/14651858.CD003336.pub4-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"17415","DOI":"10.1038\/s41598-019-53641-0","article-title":"Risk of venous thromboembolism after new onset heart failure","volume":"9","author":"Smilowitz","journal-title":"Scientific Reports"},{"key":"10.1002\/14651858.CD003336.pub4-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1161\/01.CIR.84.2.527","article-title":"Stroke Prevention in Atrial Fibrillation Investigators","volume":"84","author":"Stroke Prevention in Atrial Fibrillation (SPAF) Investigators","year":"1991","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD003336.pub4-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.amjcard.2015.06.016","article-title":"Bleeding risk and antithrombotic strategy in patients with sinus rhythm and heart failure with reduced ejection fraction treated with warfarin or aspirin","volume":"116","author":"Ye","year":"2015","journal-title":"American Journal of Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD003336.pub4-BIB0050|cit50","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003336","article-title":"Anticoagulation versus placebo for heart failure in sinus rhythm","author":"Lip","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD003336.pub4-BIB0051|cit51","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003336.pub2","article-title":"Anticoagulation versus placebo for heart failure in sinus rhythm","author":"Lip","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD003336.pub4-BIB0052|cit52","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003336.pub3","article-title":"Anticoagulation versus placebo for heart failure in sinus rhythm","author":"Lip","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,3,19]],"date-time":"2023-03-19T16:47:06Z","timestamp":1679244426000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003336.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Heart Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,5,18]]},"references-count":52,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003336.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,18]]}}}